Skip to content

13F-HR filed by Blackcrane Capital, LLC

Blackcrane Capital, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-10, with 11 holding rows worth $50,932,000.

Accession
0001720745-21-000001
Filed
2021-02-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 12 entries on the cover page, a total value of $50,932,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $50,932,000 with VALUE read as thousands by filing date, 13F file number 028-18913. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WIX COM LTD SHSM98068105Stock42,363$10,589,000thousands by filing date
NICE LTD SPONSORED ADR653656108ADR26,721$7,576,000thousands by filing date
PROFOUND MED CORP74319B502COM NEW341,767$7,029,000thousands by filing date
OPEN TEXT CORP COM683715106Stock151,800$6,900,000thousands by filing date
AXONICS INC05465P101COM124,736$6,227,000thousands by filing date
AVITA THERAPEUTICS, INC.05380C102COM308,504$5,732,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM25,641$2,198,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO69,695$1,925,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM11,499$1,102,000thousands by filing date
Microsoft Corp594918104COM4,555$1,013,000thousands by filing date
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS874060205ADR35,236$641,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001720745-21-000001this filing2021-02-10acceptance time not in the bulk data set